Apremilast in plaque psoriasis and psoriatic arthritis: No added benefit can be derived
Dossiers contained neither studies of direct comparisons nor indirect comparisons
2015-05-19
(Press-News.org) Apremilast (trade name: Otezla) has been available since January 2015 for the treatment of moderate to severe plaque psoriasis or active psoriatic arthritis in adult patients in whom certain pretreatments are not sufficiently effective or unsuitable. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in two dossier assessments whether this drug offers an added benefit over the respective appropriate comparator therapy. Such an added benefit cannot be derived from any of the dossiers however, because they contain no relevant data.
Manufacturer itself did not claim an added benefit
The drug manufacturer presented no studies in which apremilast was tested against the respective appropriate comparator therapy for any of the two therapeutic indications. It only described data from placebo-controlled studies, but did not use them for indirect comparisons.
There was also no systematic search for studies with the appropriate comparator therapy, which might be suitable for an indirect comparison with apremilast. It therefore remains unclear whether an indirect comparison would have been possible and whether this comparison would have shown an added benefit or lesser benefit of apremilast in comparison with the drugs already available. Consistently, the manufacturer itself did not claim an added benefit for the new drug in any of the two therapeutic indications.
INFORMATION:
G-BA decides on the extent of added benefit
This dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the G-BA. After publication of the dossier assessment, the G-BA conducts a commenting procedure and makes a final decision on the extent of the added benefit.
An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the Website gesundheitsinformation.de, published by IQWiG, provides easily understandable German-language Information.
More English-language information will be available soon (Sections I 2.1 to I 2.6, and Sections II 2.1 to II 2.6 of the dossier assessment as well as subsequently published health information on informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to info@iqwig.de.
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-19
An international team of more than 100 scientists, policy makers and community representatives, led by international conservation charity the Zoological Society of London (ZSL), today published a new report outlining the vital steps needed to save the Hainan gibbon (Nomascus hainanus) from extinction. With only 25 individuals remaining in less than 20 square kilometres of forest in China's Hainan Island, the Critically Endangered Hainan gibbon is one of the rarest animals in the world.
The last surviving Hainan gibbon population contains only three social groups, in ...
2015-05-19
Suffering from anxiety or depression could carry an increased risk of death from liver disease, a study suggests.
The study is the first to identify a possible link between high levels of psychological distress and deaths resulting from a variety of liver diseases.
Reasons for this are unclear as the biological links between psychological distress and liver disease are not well understood, researchers say.
Previous research suggests mental distress can put people at increased risk of cardiovascular disease. At the same time, risk factors for cardiovascular disease ...
2015-05-19
(PARIS, FRANCE) -- Experts speaking at EuroPCR 2015 say the explosion of positive results for new-generation endovascular devices for the treatment of acute stroke warrant a call to action to ensure swifter implementation of this technology. Known as "stent-retrievers," mechanical thrombectomy devices use catheters introduced into a blocked cerebral artery to suck out or lyse a clot that is cutting off circulation to part of the brain.
On Tuesday, EuroPCR 2015 featured a special breaking news session devoted to this rapidly evolving field to review the recent evidence ...
2015-05-19
(PARIS, FRANCE) - Experts participating in a European Clinical Consensus Conference (CCC) have concluded that research into the use of renal denervation for high blood pressure in patients unable to control the disease using a multi-drug regimen should not be abandoned until high-quality research is completed according to agreed-upon standards. [1]
"Focused, collaborative high-quality research will be necessary to ensure that future patients are neither denied an effective therapy, nor needlessly put at risk from procedures that bring no benefits," the authors, led by ...
2015-05-19
Sending teen girls periodic text messages reminding them to follow through on their clinic appointments for periodic birth control injections can go a long way toward improving timing and adherence to contraception in an age group that is notoriously noncompliant, according to a small study from the Johns Hopkins Children's Center.
"Our findings suggest that text messaging can help overcome some issues that teens struggle with and pose challenges for the clinicians caring for them, such as keeping clinical appointments, adhering to a tight treatment schedule and regularly ...
2015-05-19
There is a striking and statistically significant difference in how women and men are treated following a heart attack. These gender differences are reflected in the rate of risk factor control, which was lower in women, and in the rate of hospital readmission for a further heart attack, which was higher in women than in men.
The conclusions are reported today in an analysis of the SWEDEHEART registry in the European Journal of Preventive Cardiology.(1) This Swedish registry is one of the world's biggest ongoing statistical records in cardiac treatments and one of the ...
2015-05-18
Thirty-five million people worldwide are currently living with HIV-1/AIDS. Broadly neutralizing antibodies (bnAbs) have been isolated from some patients with HIV-1, and these antibodies recognize and inhibit a range of HIV-1 variants. Strategies to enhance the potency and breadth of these bnAbs have the potential to inform the development of an effective HIV-1 vaccine. A new study in the Journal of Clinical Investigation reveals that increasing the stability of an HIV-1-targeting bnAb improves efficacy. James Crowe and colleagues at Vanderbilt University used computational ...
2015-05-18
COLUMBUS, Ohio - Chest pain is a scary symptom that sends more than 7 million Americans to the emergency department each year. About half of them are admitted to the hospital for further observation, testing or treatment. Now, emergency medicine physicians at The Ohio State University Wexner Medical Center and Mount Carmel Health System believe that number can be significantly reduced.
Their study, published in today's JAMA Internal Medicine, finds a very low short-term risk for life-threatening cardiac events among patients with chest pain who have normal cardiac blood ...
2015-05-18
SAN FRANCISCO, May 18, 2015 -- Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National Academy of Sciences.
Not all drugs can reach all parts of the body, a situation known as "imperfect drug penetration." In the study, researchers found that when there is a "pocket" of the body where only one drug is present, such as the brain or the digestive system, a pathogen can quickly develop ...
2015-05-18
More than 500,000 people in the United States die each year of cancer-related causes. Now, emerging research has identified the mechanism behind one of the most common mutations that help cancer cells replicate limitlessly.
Approximately 85 percent of cancer cells obtain their limitless replicative potential through the reactivation of a specific protein called telomerase (TERT). Recent cancer research has shown that highly recurrent mutations in the promoter of the TERT gene are the most common genetic mutations in many cancers, including adult glioblastoma and hepatocellular ...
LAST 30 PRESS RELEASES:
[Press-News.org] Apremilast in plaque psoriasis and psoriatic arthritis: No added benefit can be derived
Dossiers contained neither studies of direct comparisons nor indirect comparisons
